As an oncogene, DDX5 is overexpressed in many tumours, promoting tumour cell growth and metastasis, including cancers of the breast, colon, prostate, non-small cell lung cancer (NSCLC) and glioma [10–13]. Here, DDX5 is linked to breast carcinoma.